SUBSCRIBE
SUBSCRIBE

Virginia

Illustration of a bald eagle swooping down on a factory
BIOSECURE Act
US Manufacturing Unprepared for BIOSECURE Act’s Repercussions
As the pharma industry awaits congressional action on the bill, gaping holes in the domestic drug manufacturing ecosystem have never been clearer.
August 21, 2024
 · 
5 min read
 · 
Keerthi Vedantam
Feet of a person with red-painted toenails as the person steps onto a weight scale.
Cardiovascular disease
Rivus Targets Weight-Loss Drug Market With Mid-Stage Win in Obesity-Related Heart Failure
Rivus Pharmaceuticals will push HU6 into Phase III development and is looking to engage with regulatory authorities and launch a late-stage study next year in obesity-related heart failure with preserved ejection fraction.
August 14, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Press Releases
Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study
December 19, 2024
 · 
5 min read
Press Releases
Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies
December 18, 2024
 · 
5 min read
Press Releases
CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study
December 12, 2024
 · 
13 min read
Press Releases
New ALS Association-Led Research Finds Specialists Diagnose ALS Twice as Fast as General Neurologists
December 11, 2024
 · 
4 min read
Press Releases
Qnovia, Inc. Raises $16 Million in Series B Financing to Advance Lead Asset RespiRx™ Nicotine Inhaler as a Prescription Smoking Cessation Therapy
December 10, 2024
 · 
3 min read
Press Releases
ReAlta Life Sciences Announces Positive Preclinical Data for RLS-0071 (pegtarazimod) in Acute Graft-Versus-Host Disease (aGVHD) at American Society of Hematology Annual Meeting
December 9, 2024
 · 
4 min read
Press Releases
Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations
December 3, 2024
 · 
5 min read
Press Releases
Leading Health Organizations Urge Flu Vaccination for Those at Higher Risk
December 3, 2024
 · 
7 min read
Press Releases
Melinta Joins NHIA Future of Infusion Advisory Council
December 2, 2024
 · 
3 min read
Press Releases
Slope and LabConnect Unveil Groundbreaking Bidirectional API Integration for Clinical Trials
November 25, 2024
 · 
3 min read
Press Releases
TearSolutions, Inc. Secures $3M Series B Funding
November 22, 2024
 · 
1 min read
Press Releases
ReAlta Life Sciences Announces Appointment of Distinguished Biopharmaceutical Leader Lewis T. “Rusty” Williams, M.D., Ph.D. as Chairman of the Board
November 21, 2024
 · 
4 min read
Press Releases
NAMI Welcomes Mike Wood as Chief Operating Officer
November 20, 2024
 · 
1 min read
Press Releases
Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024
November 19, 2024
 · 
10 min read
Press Releases
Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
November 15, 2024
 · 
7 min read
Press Releases
CMS Confirms Coverage of Kerecis Fish-Skin Products by Medicare
November 15, 2024
 · 
3 min read
Press Releases
Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
November 13, 2024
 · 
7 min read
Press Releases
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2024 Financial Results
November 7, 2024
 · 
8 min read
Press Releases
U.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025
November 7, 2024
 · 
4 min read
Press Releases
Quoin Pharmaceuticals Initiates Clinical Testing of Lead Product in Pediatric Netherton Syndrome Patient
November 6, 2024
 · 
6 min read
Load More